EOJOAM
WST icon

E. Ohman J:or Asset Management’s West Pharmaceutical WST Stock Holding History

E. Ohman J:or Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.41M Sell
3,932
-533
-12% -$163K 0.03% 252
2026
Q1 		$1.12M Buy
4,465
+1,426
+47% +$355K 0.03% 268
2025
Q4 		$836K Hold
3,039
– – 0.02% 326
2025
Q3 		$797K Hold
3,039
– – 0.02% 306
2025
Q2 		$665K Hold
3,039
– – 0.02% 327
2025
Q1 		$680K Sell
3,039
-400
-12% -$110K 0.02% 323
2024
Q4 		$1.13M Buy
3,439
+500
+17% +$157K 0.03% 266
2024
Q3 		$882K Hold
2,939
– – 0.02% 279
2024
Q2 		$968K Hold
2,939
– – 0.02% 258
2024
Q1 		$1.16M Hold
2,939
– – 0.03% 230
2023
Q4 		$1.03M Sell
2,939
-400
-12% -$142K 0.04% 224
2023
Q3 		$1.25M Hold
3,339
– – 0.05% 206
2023
Q2 		$1.28M Hold
3,339
– – 0.05% 224
2023
Q1 		$1.16M Hold
3,339
– – 0.05% 222
2022
Q4 		$786K Hold
3,339
– – 0.03% 276
2022
Q3 		$822K Hold
3,339
– – 0.04% 259
2022
Q2 		$1.01M Hold
3,339
– – 0.04% 232
2022
Q1 		$1.37M Hold
3,339
– – 0.05% 229
2021
Q4 		$1.57M Hold
3,339
– – 0.05% 232
2021
Q3 		$1.42M Sell
3,339
-300
-8% -$126K 0.04% 237
2021
Q2 		$1.31M Hold
3,639
– – 0.04% 253
2021
Q1 		$1.03M Buy
3,639
+700
+24% +$200K 0.04% 261
2020
Q4 		$833K Hold
2,939
– – 0.03% 254
2020
Q3 		$808K Hold
2,939
– – 0.04% 206
2020
Q2 		$668K Buy
2,939
+700
+31% +$138K 0.04% 217
2020
Q1 		$341K Sell
2,239
-1,800
-45% -$277K 0.03% 271
2019
Q4 		$607K Buy
+4,039
New +$588K 0.03% 268

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

E. Ohman J:or Asset Management's WST Position: Q2 2026 in Review

E. Ohman J:or Asset Management reduced its West Pharmaceutical (WST) stake by 12% in Q2 2026, selling an estimated $163K and leaving 3,932 shares worth $1.41M. The position accounts for 0.03% of the portfolio, ranked #252.

E. Ohman J:or Asset Management first reported a position in WST in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.57M in Q4 2021. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • E. Ohman J:or Asset Management held 3,932 shares of West Pharmaceutical worth $1.41M as of Q2 2026.
  • E. Ohman J:or Asset Management sold 533 West Pharmaceutical shares in Q2 2026, an estimated $163K.
  • West Pharmaceutical made up 0.03% of E. Ohman J:or Asset Management's portfolio in Q2 2026, its #252 holding.
  • E. Ohman J:or Asset Management first reported a position in West Pharmaceutical in Q4 2019 and has held it in 27 quarters since.
  • E. Ohman J:or Asset Management's West Pharmaceutical position peaked at $1.57M in Q4 2021.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on E. Ohman J:or Asset Management's 13F filing for Q2 2026, filed 10 Jul 2026.